Pharmacological characterization of the selective 11β-hydroxysteroid dehydrogenase 1 inhibitor, BI 135585, a clinical candidate for the treatment of type 2 diabetes.
暂无分享，去创建一个
H. Nar | B. Hamilton | D. Lala | F. Himmelsbach | D. Claremon | Yi Zhao | Joan Guo | Shi Meng | P. Krosky | G. Mcgeehan | L. Zhuang | Rong Guo | A. Schuler-Metz | G. McGeehan | Linghang Zhuang | Annette Schuler-Metz